BN Business News
Add your company to Business Communicator →

Labour market · 17/11/20261 min read

Laboratoires Pierre Fabre: FDA Fast Track designation for elticertinib in NSCLC

EDITORIAL ILLUSTRATIONLMLabour marketBN
Illustration generated by Business News; it is not a source photograph.

Summary

CASTRES, France, Nov. 17, 2026 — Laboratoires Pierre Fabre announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to elticertinibi (also known as PFL-721 previously STX-721), for the treatment of adult patients with locally advanced or...

Original source language: PR Newswire UK — News ReleasesOpen original release →

Explore insights

Business insights →